These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8027238)

  • 1. c-myc, c-fos, and c-myb gene expression in human pituitary adenomas.
    Woloschak M; Roberts JL; Post K
    J Clin Endocrinol Metab; 1994 Jul; 79(1):253-7. PubMed ID: 8027238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of c-myc and c-fos and binding sites for estradiol and progesterone in human pituitary tumors.
    Machiavelli GA; Rivolta CM; Artese R; Basso A; Burdman JA
    Neurol Res; 1998 Dec; 20(8):709-12. PubMed ID: 9864735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 (IL-2) and IL-6 regulate c-fos protooncogene expression in human pituitary adenoma explants.
    Pereda MP; Goldberg V; Chervín A; Carrizo G; Molina A; Andrada J; Sauer J; Renner U; Stalla GK; Arzt E
    Mol Cell Endocrinol; 1996 Nov; 124(1-2):33-42. PubMed ID: 9027322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras mutations in human pituitary tumors.
    Karga HJ; Alexander JM; Hedley-Whyte ET; Klibanski A; Jameson JL
    J Clin Endocrinol Metab; 1992 Apr; 74(4):914-9. PubMed ID: 1312542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncoprotein immunoreactivity in human pituitary tumours.
    Raghavan R; Harrison D; Ince PG; James RA; Daniels M; Birch P; Caldwell GI; Kendall-Taylor P
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):117-26. PubMed ID: 8306470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study on the transcriptional expression of oncogenes in human primary brain tumors].
    Sun N; Wen Y; Yan S; Sun Z; Zhou R; Liao W
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Jun; 24(2):135-8. PubMed ID: 8244289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.
    Zhang X; Horwitz GA; Heaney AP; Nakashima M; Prezant TR; Bronstein MD; Melmed S
    J Clin Endocrinol Metab; 1999 Feb; 84(2):761-7. PubMed ID: 10022450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
    Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic studies of sporadic pituitary tumors.
    Boggild MD; Jenkinson S; Pistorello M; Boscaro M; Scanarini M; McTernan P; Perrett CW; Thakker RV; Clayton RN
    J Clin Endocrinol Metab; 1994 Feb; 78(2):387-92. PubMed ID: 8106627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Overexpression of c-myc, c-fos and Harvey ras oncogenes in renal cancers--analysis at the messenger RNA levels].
    Kunimi K; Uchibayashi T; Hisazumi H
    Nihon Hinyokika Gakkai Zasshi; 1991 Dec; 82(12):1924-9. PubMed ID: 1779495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary specific transcription factor messenger ribonucleic expression in adenomatous and nontumorous human pituitary tissues.
    Lloyd RV; Jin L; Chandler WF; Horvath E; Stefaneanu L; Kovacs K
    Lab Invest; 1993 Nov; 69(5):570-5. PubMed ID: 8246449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.
    Pierantoni GM; Finelli P; Valtorta E; Giardino D; Rodeschini O; Esposito F; Losa M; Fusco A; Larizza L
    Endocr Relat Cancer; 2005 Dec; 12(4):867-74. PubMed ID: 16322327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of c-myc and c-fos protooncogenes in the anterior pituitary gland of the rat. Effect of estrogen.
    Szijan I; Parma DL; Engel NI
    Horm Metab Res; 1992 Apr; 24(4):154-7. PubMed ID: 1601388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenes with potential nuclear function: myc, myb and fos.
    Eisenman RN; Thompson CB
    Cancer Surv; 1986; 5(2):309-27. PubMed ID: 3779660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A relation between c-myc expression and prognosis of leukemia patients in Indonesia.
    Haryana SM
    Kobe J Med Sci; 1994 Aug; 40(3-4):91-105. PubMed ID: 7739203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
    Ishiguro N; Matsui T; Shinagawa M
    Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.